 |
AFFiRiS
Last updated: August 03, 2025
Founders: Walter Schmidt and Frank Mattner
Austria | Funding: $57,5m (+)
Website: http://www.affiris.com
AFFiRiS develops first-in-class antigen specific immunotherapies for the prevention and treatment of chronic illnesses on the basis of our proprietary AFFITOME technology. We have a conviction that active immunization can play a major role in prevention and therapy of chronic civilization illnesses such as Atherosclerosis, Diabetes or Neurodegenerative Diseases.
Website: http://www.affiris.com
AFFiRiS develops first-in-class antigen specific immunotherapies for the prevention and treatment of chronic illnesses on the basis of our proprietary AFFITOME technology. We have a conviction that active immunization can play a major role in prevention and therapy of chronic civilization illnesses such as Atherosclerosis, Diabetes or Neurodegenerative Diseases.
